/Investor DB

MPM BioImpact — 2016 Investments

4 investments dated 2016 · listed companies and verified rows first · show all

OncorusinSeries A · Mar 2016 · $57M

Cambridge, US

Christophe Queva(Executive Officer)inTheodore Ashburn(Executive Officer, Director)Alon Lazarus(Director)Cameron Wheeler(Director)in

Board seatMitchell FinerLuke EvninBriggs Morrison· per SEC Form D

Co-investorsAstellas Venture Management LLCCowen Healthcare InvestmentsDeerfield Management CompanyIMM InvestmentK2 HealthVenturesSphera Funds Management

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Blade TherapeuticsTrieza TherapeuticsTCR2

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.